Related Experiment Videos
High-resolution crystal structure of deoxy hemoglobin complexed with a potent allosteric effector
M K Safo1, C M Moure, J C Burnett
1Department of Medicinal Chemistry, School of Pharmacy and Institute for Structural Biology and Drug Discovery, Virginia Commonwealth University, Richmond, Virginia 23298-0540, USA.
Protein Science : a Publication of the Protein Society
|April 24, 2001
Summary
The crystal structure reveals how RSR-13 binds to human deoxyhemoglobin (Hb), enhancing oxygen delivery. This structural insight aids in developing new therapeutics for conditions like hypoxia and cancer.
Area of Science:
- Biochemistry
- Structural Biology
- Pharmacology
Background:
- Human deoxyhemoglobin (Hb) is crucial for oxygen transport.
- Allosteric effectors can modulate Hb function.
- RSR-13 is an effector with potential therapeutic applications.
Purpose of the Study:
- To determine the crystal structure of human deoxyhemoglobin complexed with RSR-13.
- To elucidate the binding interactions and structural constraints imposed by RSR-13 on deoxyhemoglobin.
- To understand the structural basis for RSR-13's physiological effects.
Main Methods:
- X-ray crystallography at 1.85 A resolution.
- Structural analysis of the hemoglobin:effector complex.
- Analysis of hydrogen bonding and hydrophobic interactions.
Main Results:
- Two RSR-13 molecules bind symmetrically in the central water cavity of deoxy Hb.
- RSR-13 engages with three of the four Hb subunits via hydrogen bonding and hydrophobic interactions.
- Water-mediated interactions significantly contribute to the binding affinity.
Conclusions:
- The detailed structure explains RSR-13's mechanism of increasing oxygen delivery.
- This compound shows therapeutic potential for hypoxia, ischemia, and trauma.
- Structural insights facilitate the rational design of novel RSR-13 analogs for improved therapeutic outcomes.